GlassScriptPhysician profile
Daniel Aaron Schneider
NPI 1508071846
$3,861.00
in general payments reported to CMS, 2019-2025
39 companies · $663 in 2025
The $663 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $584 · 2020: $75.67 · 2021: $356 · 2022: $682 · 2023: $883 · 2024: $617 · 2025: $663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,163.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $644.15 | 2019-2025 | Lifevest |
| Abbott Laboratories | $435.89 | 2019-2024 | Amplatzer Amulet, Jot Dx, Perclose Prostyle |
| Pfizer INC. | $308.47 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $209.68 | 2019-2025 | Jardiance |
| Boston Scientific Corporation | $204.49 | 2019-2025 | Watchman Access System, Cds - Mct/Cem Monitoring, General - Ep |
| Janssen Pharmaceuticals, INC | $195.57 | 2019-2023 | Xarelto |
| Cardiva Medical, INC. | $183.69 | 2019-2025 | Savvywire, Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f |
| Amgen INC. | $132.86 | 2021-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $119.93 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $116.27 | 2019-2023 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $102.13 | 2019-2025 | Farxiga, Lokelma |
| Biosense Webster, INC. | $96.81 | 2022 | |
| Alnylam Pharmaceuticals INC. | $90.47 | 2023-2025 | Onpattro |
| Medtronic, INC. | $90.36 | 2022-2024 | Corevalve Evolut R, Linq II |
| Baxter Healthcare | $86.74 | 2023 | Hillrom - Carnation Ambulatory Monitor |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $75.62 | 2019-2023 | |
| Scpharmaceuticals INC. | $73.44 | 2023-2025 | |
| Teleflex LLC | $65.41 | 2022 | |
| Atricure, INC. | $63.79 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Elutia, INC. | $57.99 | 2021-2023 | |
| Amarin Pharma, INC. | $56.67 | 2019 | |
| Abiomed | $50.36 | 2025 | |
| Penumbra, INC. | $47.70 | 2024 | Indigo System |
| Actelion Pharmaceuticals US, INC. | $44.40 | 2023-2025 | Opsumit, Uptravi |
| Novo Nordisk INC | $34.16 | 2023-2024 | Wegovy, Ozempic, Rybelsus |
| Edwards Lifesciences Corporation | $31.73 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Merck Sharp & Dohme LLC | $31.62 | 2022-2023 | Verquvo |
| Cvrx, INC. | $22.18 | 2024 | Barostim Neo System |
| Esperion Therapeutics, INC. | $19.66 | 2021 | |
| Irhythm Technologies, INC. | $19.39 | 2019 | |
| Lundbeck LLC | $18.89 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $18.79 | 2023 | Inpefa |
| Heartflow, INC. | $18.18 | 2024 | |
| Cook Medical LLC | $17.72 | 2022 | |
| Impulse Dynamics (USA) INC. | $17.22 | 2023 | Optimizer |
| Kestra Medical Technology Services, INC. | $15.30 | 2025 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $15.07 | 2025 | |
| Bridgebio Pharma, INC. | $14.55 | 2025 | Attruby |
| Gilead Sciences, INC. | $13.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Schneider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.